MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Secondary malignant neoplasm of unspecified ovary (C79.60)

HealthDay 13 June at 11.17 AM

J&J Settles Talcum Powder Lawsuits From States for $700 Million

Johnson & Johnson will pay $700 million to settle claims from 42 states and the District of Columbia that the company continued to market its talcum powder products even as evidence tied them to a heightened risk for cancer.J&J did not admit to any wrongdoing in settling with the states, which were led by Florida, Texas and North Carol

Evalytics 01 April at 06.18 PM

Princess Kate is undergoing 'preventative chemotherapy.' What does that mean?

Princess Kate Middleton's decision for risk-reducing surgery to prevent ovarian cancer has sparked discussions about genetic testing and cancer prevention. This highlights the importance of genetic counseling and testing for those with a family history of cancer to assess and mitigate their risk.

HealthDay 11 December at 04.44 PM

Early Diagnosis of High-Grade Serous Ovarian Cancer Feasible

Early diagnosis of high-grade serous ovarian cancer (HGSOC) seems feasible through analysis of genomic alterations in DNA from Papanicolaou (Pap) test smears, according to a study published online Dec. 6 in Science Translational Medicine.Lara Paracchini, Ph.D., from Humanitas University in Milan, and colleagues examined a retrospective

HealthDay 07 December at 04.50 PM

Mirvetuximab Soravtansine-Gynx Beneficial for FRα-Positive Ovarian Cancer

For patients with high folate receptor α (FRα)-positive ovarian cancer, a first-in-class antibody-drug conjugate targeting FRα, mirvetuximab soravtansine-gynx (MIRV), shows a significant benefit over chemotherapy, according to a study published in the Dec. 7 issue of the New England Journal of Medicine.Kathleen N. Moore, M.D., from the